Catalyst Wire Dossier Catalyst Wire Dossier

CUVPOSA

glycopyrrolate · Merz Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CUVPOSA, covering 2010-07-28 to 2018-02-23. Get the full timeline:

Most recent: FDA Approved: CUVPOSA — Supplemental Application (Merz Pharmaceuticals, LLC)

See pricing